Purpose
The purpose of this study was to quantitatively clarify the contribution of the absorption, protein binding, and metabolism of cytochrome P450 enzymes to the enantioselective pharmacokinetics of pantoprazole enantiomers in rats.
Methods
The enantioselective pharmacokinetics of pantoprazole enantiomers was estimated by an oral administration of racemic pantoprazole to rats. The pharmacokinetic differences between pantoprazole enantiomers were evaluated by the experiments of the in situ perfusion into rat small intestine, the protein binding, and the in vitro metabolism in rat liver microsomes of pantoprazole enantiomers.
Results
The mean area under the curve value of S-pantoprazole was 1.5 times greater than that of R-pantoprazole after administration of racemic pantoprazole to rats (20 mg/kg, p.o.). There were significant differences in ke (p < 0.05), t1/2 (p < 0.01), and mean residence time (p < 0.01) values between the two enantiomers. In the in situ absorption study, the absorption rate constants were of no significant differences between the two enantiomers. The mean unbound fraction of R-pantoprazole was slightly greater than that of S-pantoprazole. The intrinsic clearance (CLint) of the formation of the 5′-O-demethyl metabolite from S-pantoprazole was 4-fold lower than that from R-pantoprazole. However, the CLint value for the sulfone and 6-hydroxy metabolites from S-pantoprazole was higher than that from R-pantoprazole. The sum of the CLint of the formation of all three metabolites was 3.06 and 4.82 mL/min/mg protein for S- and R-pantoprazole, respectively.
Conclusions
This study suggests that the enantioselective pharmacokinetics of pantoprazole enantiomers in rats is probably ascribable to their enantioselective metabolism, which is contributed by all the three metabolic pathways, including sulfoxide oxidation, 4′-O-demethylation, and 6-hydroxylation.
Similar content being viewed by others
References
P. Lindberg P. Nordberg T. Alminger A. Brandstrom B. Wallmark (1986) ArticleTitleThe mechanism of action of the gastric acid secretion inhibitor omeprazole J. Med. Chem. 29 1327–1329 Occurrence Handle10.1021/jm00158a001 Occurrence Handle3016260
A. Fitton L. Wiseman (1996) ArticleTitlePantoprazole: a review of its pharmacological properties and therapeutic use in acid-related disorders Drugs 51 460–482 Occurrence Handle8882382
P.W. Jungnickel (2000) ArticleTitlePantoprazole: a new proton pump inhibitor Clin. Ther. 22 1268–1293 Occurrence Handle10.1016/S0149-2918(00)83025-8 Occurrence Handle11117653
W. A. Simon (1995) ArticleTitlePantoprazole—Which cytochrome P450 isoenzymes are involved in its biotransformation Gut 37 IssueIDSuppl. 2 A135
A. M. Cairns R. H. Chiou J. D. Rogers J. L. Demetriades (1995) ArticleTitleEnantioselective high-performance liquid chromatographic determination of omeprazole in human plasma J. Chromatogr. 666 323–328
G. Tybring Y. Bottiger J. Widen L. Bertilsson (1997) ArticleTitleEnantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects Clin. Pharmacol. Ther. 62 129–137 Occurrence Handle10.1016/S0009-9236(97)90060-6 Occurrence Handle9284848
M. Tanaka T. Ohkubo K. Otani A. Suzuki S. Kaneko K. Sugawara Y. Ryokawa T. Ishizaki (2001) ArticleTitleStereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin Clin. Pharmacol. Ther. 69 108–113 Occurrence Handle10.1067/mcp.2001.113723 Occurrence Handle11240974
M. Tanaka H. Yamazaki H. Hakusui N. Nakamichi H. Sekino (1997) ArticleTitleDifferential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole: a preliminary study Chirality 9 17–21 Occurrence Handle10.1002/(SICI)1520-636X(1997)9:1<17::AID-CHIR4>3.0.CO;2-D Occurrence Handle9094198
H. Katsuki H. Yagi K. Arimori C. Nakamura M. Nakano S. Katafuchi Y. Fujioka S. Fujiyama (1996) ArticleTitleDetermination of R(+)- and S(−)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans Pharm. Res. 13 611–615 Occurrence Handle10.1023/A:1016062508580 Occurrence Handle8710755
K. Kim J. Shon J. Park Y. Yoon M. Kim D. Yun M. Kim I. Cha M. Hyun J. Shin (2002) ArticleTitleEnantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19 Clin. Pharmacol. Ther. 72 90–99 Occurrence Handle10.1067/mcp.2002.126176 Occurrence Handle12152007
S. Takakuwa S. Chiku H. Nakata T. Yuzuriha N. Mano N. Asakawa (1995) ArticleTitleEnantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in Beagle dog plasma and rat plasma J. Chromatogr., B 673 113–122
N. Mano Y. Oda S. Takakuwa S. Chiku H. Nakata N. Asakawa (1996) ArticleTitlePlasma direct injection high-performance liquid chromatographic method for simultaneous determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column J. Pharm. Sci. 85 903–907 Occurrence Handle10.1021/js960172n Occurrence Handle8877876
A. Abelo T. B. Andersson M. Antonsson A. K. Naudot I. Skanberg L. Weidolf (2000) ArticleTitleStereoselective metabolism of omeprazole by human cytochrome P450 enzymes Drug Metab. Dispos. 28 966–972 Occurrence Handle10901708
K. Arimori K. Yasuda H. Katsuki M. Nakano (1998) ArticleTitlePharmacokinetic differences between lansoprazole enantiomers in rats J. Pharm. Pharmacol. 50 1241–1245 Occurrence Handle9877309
K. Masa A. Hamada K. Arimori J. Fujii M. Nakano (2001) ArticleTitlePharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs Biol. Pharm. Bull. 24 274–277 Occurrence Handle10.1248/bpb.24.274 Occurrence Handle11256484
K. A. Kim M. J. Kim J. Y. Park J. H. Shon Y. R. Yoon S. S. Lee K. H. Liu J. H. Chun M. H. Hyun J. G. Shin (2003) ArticleTitleStereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes Drug Metab. Dispos. 31 1227–1234 Occurrence Handle10.1124/dmd.31.10.1227 Occurrence Handle12975331
A. Abelo T. B. Andersson U. Bredberg I. Skanberg L. Weidolf (2000) ArticleTitleStereoselective metabolism by human liver CYP enzymes of a substituted benzimidazole Drug Metab. Dispos. 28 58–64 Occurrence Handle10611141
N. Masubuchi H. Yamazaki M. Tanaka (1998) ArticleTitleStereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats Chirality 10 747–753 Occurrence Handle10.1002/(SICI)1520-636X(1998)10:8<747::AID-CHIR5>3.0.CO;2-B Occurrence Handle9803530
H. Hirayama X. Xu K. S. Pang (1989) ArticleTitleViability of the vascularly perfused, recirculating rat intestine and intestine–liver preparations Am. J. Physiol. 257 G249–G258 Occurrence Handle2764110
L. Ernster P. Siekevitz G. E. Palada (1962) ArticleTitleEnzyme–structure relationships in the endoplasmic reticulum of rat liver J. Cell Biol. 15 541–562 Occurrence Handle10.1083/jcb.15.3.541
O. H. Lowry N. J. Rosebrough A. L. Farr R. J. Randall (1951) ArticleTitleProtein measurement with the folin phenol reagent J. Biol. Chem. 193 175–265 Occurrence Handle14907703
K. Yanaoka Y. Tanigawara T. Nakagawa T. Iga (1981) ArticleTitleA pharmacokinetic analysis program (MULTI) for microcomputer J. Pharmacobio-Dyn. 4 879–885 Occurrence Handle7328489
D. F. Zhong Z. Y. Xie X. Y. Chen (2005) ArticleTitleMetabolism of pantoprazole involving conjugation with glutathione in rats J. Pharm. Pharmacol. 57 341–349 Occurrence Handle10.1211/0022357055669 Occurrence Handle15807990
Z. Y. Xie B. H. Yang Y. F. Zhang D. F. Zhong (2004) ArticleTitleStudies on chiral inversion of dextro-pantoprazole in human Acta Pharm. Sin. 39 370–373
N. Mano Y. Oda S. Takakuwa T. Yuzuriha N. Mano N. Asakawa (1996) ArticleTitlePlasma direct injection high-performance liquid chromatographic method for simultaneously determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated column J. Pharm. Sci. 85 903–907 Occurrence Handle10.1021/js960172n Occurrence Handle8877876
H. Stenhoff A. Blomqvist P. O. Lagerstrom (1999) ArticleTitleDetermination of the enantiomers of omeprazole in blood plasma by normal-phase liquid chromatography and detection by atmospheric pressure ionization tandem mass spectrometry J. Chromatogr., B 734 191–201
R. Huber B. Kohl G. Sachs J. Senn-Bilfinger W. A. Simon E. Sturm (1995) ArticleTitleThe continuing development of proton pump inhibitor, with particular reference to pantoprazole Aliment. Pharmacol. Ther. 9 363–378 Occurrence Handle8527612
Acknowledgment
This work was supported in part by Grant 2003AA2Z347C of the “863” Program of China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xie, Z., Zhang, Y., Xu, H. et al. Pharmacokinetic Differences between Pantoprazole Enantiomers in Rats. Pharm Res 22, 1678–1684 (2005). https://doi.org/10.1007/s11095-005-6807-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-005-6807-x